| Neurotransmitter modulation by the gut microbiota P Strandwitz Brain research 1693, 128-133, 2018 | 1117 | 2018 |
| GABA-modulating bacteria of the human gut microbiota P Strandwitz, KH Kim, D Terekhova, JK Liu, A Sharma, J Levering, ... Nature microbiology 4 (3), 396-403, 2019 | 775 | 2019 |
| American gut: an open platform for citizen science microbiome research D McDonald, E Hyde, JW Debelius, JT Morton, A Gonzalez, G Ackermann, ... Msystems 3 (3), 10.1128/msystems. 00031-18, 2018 | 657 | 2018 |
| Quinones are growth factors for the human gut microbiota K Fenn, P Strandwitz, EJ Stewart, E Dimise, S Rubin, S Gurubacharya, ... Microbiome 5, 1-11, 2017 | 96 | 2017 |
| Cranberry extracts promote growth of Bacteroidaceae and decrease abundance of Enterobacteriaceae in a human gut simulator model K O’Connor, M Morrissette, P Strandwitz, M Ghiglieri, M Caboni, H Liu, ... PLoS One 14 (11), e0224836, 2019 | 33 | 2019 |
| GABA-modulating bacteria of the human gut microbiota. Nat Microbiol 4: 396–403 P Strandwitz, KH Kim, D Terekhova, JK Liu, A Sharma, J Levering, ... | 33 | 2019 |
| A distinct microbiome signature in posttreatment Lyme disease patients M Morrissette, N Pitt, A González, P Strandwitz, M Caboni, AW Rebman, ... MBio 11 (5), 10.1128/mbio. 02310-20, 2020 | 23 | 2020 |
| Antibiotics right under our nose K Lewis, P Strandwitz Nature 535 (7613), 501-502, 2016 | 18 | 2016 |
| Feasibility, acceptability, and safety of faecal microbiota transplantation in the treatment of major depressive disorder: a pilot randomized controlled trial JE Green, M Berk, M Mohebbi, A Loughman, AJ McGuinness, D Castle, ... The Canadian Journal of Psychiatry 68 (5), 315-326, 2023 | 10 | 2023 |
| Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system P Strandwitz, K Lewis US Patent 11,116,804, 2021 | 10 | 2021 |
| Systematic comparisons between Lyme disease and post-treatment Lyme disease syndrome in the US with administrative claims data MK Chung, M Caboni, P Strandwitz, A D'Onofrio, K Lewis, CJ Patel EBioMedicine 90, 2023 | 6 | 2023 |
| Safety and feasibility of faecal microbiota transplant for major depressive disorder: study protocol for a pilot randomised controlled trial JE Green, AJ McGuinness, M Berk, D Castle, E Athan, C Hair, ... Pilot and feasibility studies 9 (1), 5, 2023 | 5 | 2023 |
| An in vitro intestinal model captures immunomodulatory properties of the microbiota in inflammation JY Lock, M Caboni, P Strandwitz, M Morrissette, K DiBona, BA Joughin, ... Gut Microbes 14 (1), 2039002, 2022 | 4 | 2022 |
| Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system P STRANDWITZ, K Lewis | 2 | 2019 |
| Nourishing the brain on deep space missions: nutritional psychiatry in promoting resilience NN Pathare, F Fayet-Moore, JA Fogarty, FN Jacka, P Strandwitz, ... Frontiers in Neural Circuits 17, 1170395, 2023 | 1 | 2023 |
| Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system P Strandwitz, K Lewis US Patent App. 17/396,330, 2022 | 1 | 2022 |
| A distinct microbiome signature in posttreatment Lyme disease patients. mBio 11: e02310-20 M Morrissette, N Pitt, A González, P Strandwitz, M Caboni, AW Rebman, ... | 1 | 2020 |
| Microbes make metabolic mischief by targeting drugs K Lewis, P Strandwitz Nature 570 (7762), 453-454, 2019 | 1 | 2019 |
| MICROBIOLOGY Metabolic mischief as microbes target drugs K Lewis, P Strandwitz Nature 570 (7762), 453-454, 2019 | 1 | 2019 |
| Corrigendum to “Systematic comparisons between Lyme disease and post-treatment Lyme disease syndrome in the US with administrative claims data” MK Chung, M Caboni, P Strandwitz, A D'Onofrio, K Lewis, CJ Patel EBioMedicine 93, 2023 | | 2023 |
